Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Delirium × Dexmedetomidine × Clear all

Phase

Phase 4 2 Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pheochromocytoma 1 Pain, Intractable 1 Obesity 1 Non-functioning Pituitary Adenoma 1 Neoplasms 1 Nausea 1 Intrathecal Dexmedetomidine 1 Dyspnea 1 Delirium 1 Death 1

Interventions

haloperidol decanoate 1 Surveys and Questionnaires 1 Midazolam 1 Lorazepam 1 Dexmedetomidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01687751 2015-05-25

Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients

Fraser Health

Phase 2 Withdrawn

Death, Delirium, Dyspnea, Nausea, Neoplasms, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡